Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Mazzanti

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Investigational New Drugs|January 15, 2013
Effect of the drug transporters ABCG2, Abcg2, ABCB1 and ABCC2 on the disposition, brain accumulation and myelotoxicity of the aurora kinase B inhibitor barasertib and its more active form barasertib-hydroxy-QPASerena Marchetti, Dick Pluim, Monique van Eijndhoven, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|October 22, 2004
Survival and prognostic factors in patients with hepatocellular carcinoma treated by percutaneous ethanol injection: a 10-year experienceRoberto Mazzanti, Umberto Arena, Pietro Pantaleo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2013
Abcc4 together with abcb1 and abcg2 form a robust cooperative drug efflux system that restricts the brain entry of camptothecin analoguesFan Lin, Serena Marchetti, Dick Pluim, et al.
Oncology Research|December 7, 2019
Vinorelbine in Non-Small Cell Lung Cancer: Real-World Data From a Single-Institution ExperienceStefania Nobili, Daniele Lavacchi, Gabriele Perrone, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 10, 2004
The endocannabinoid 2-arachidonylglycerol decreases the immunological activation of Guinea pig mast cells: involvement of nitric oxide and eicosanoidsAlfredo Vannacci, Lucia Giannini, Maria Beatrice Passani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancerFabio Cianchi, Camillo Cortesini, Ornella Fantappiè, et al.
Molecular Cancer Therapeutics|December 20, 2007
In vitro transport of gimatecan (7-t-butoxyiminomethylcamptothecin) by breast cancer resistance protein, P-glycoprotein, and multidrug resistance protein 2Serena Marchetti, Roos L Oostendorp, Dick Pluim, et al.
Cancer Letters|August 1, 2014
Delivery of doxorubicin across the blood-brain barrier by ondansetron pretreatment: a study in vitro and in vivoIacopo Sardi, Ornella Fantappiè, Giancarlo la Marca, et al.
Molecular Cancer Therapeutics|August 30, 2008
Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1-/-/Mdr1a/1b-/- (triple-knockout) and wild-type miceSerena Marchetti, Nienke A de Vries, Tessa Buckle, et al.
The American Journal of Pathology|February 25, 2003
Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesisFabio Cianchi, Camillo Cortesini, Ornella Fantappiè, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Investigational New Drugs|January 15, 2013
Effect of the drug transporters ABCG2, Abcg2, ABCB1 and ABCC2 on the disposition, brain accumulation and myelotoxicity of the aurora kinase B inhibitor barasertib and its more active form barasertib-hydroxy-QPASerena Marchetti, Dick Pluim, Monique van Eijndhoven, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|October 22, 2004
Survival and prognostic factors in patients with hepatocellular carcinoma treated by percutaneous ethanol injection: a 10-year experienceRoberto Mazzanti, Umberto Arena, Pietro Pantaleo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2013
Abcc4 together with abcb1 and abcg2 form a robust cooperative drug efflux system that restricts the brain entry of camptothecin analoguesFan Lin, Serena Marchetti, Dick Pluim, et al.
Oncology Research|December 7, 2019
Vinorelbine in Non-Small Cell Lung Cancer: Real-World Data From a Single-Institution ExperienceStefania Nobili, Daniele Lavacchi, Gabriele Perrone, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 10, 2004
The endocannabinoid 2-arachidonylglycerol decreases the immunological activation of Guinea pig mast cells: involvement of nitric oxide and eicosanoidsAlfredo Vannacci, Lucia Giannini, Maria Beatrice Passani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancerFabio Cianchi, Camillo Cortesini, Ornella Fantappiè, et al.
Molecular Cancer Therapeutics|December 20, 2007
In vitro transport of gimatecan (7-t-butoxyiminomethylcamptothecin) by breast cancer resistance protein, P-glycoprotein, and multidrug resistance protein 2Serena Marchetti, Roos L Oostendorp, Dick Pluim, et al.
Cancer Letters|August 1, 2014
Delivery of doxorubicin across the blood-brain barrier by ondansetron pretreatment: a study in vitro and in vivoIacopo Sardi, Ornella Fantappiè, Giancarlo la Marca, et al.
Molecular Cancer Therapeutics|August 30, 2008
Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1-/-/Mdr1a/1b-/- (triple-knockout) and wild-type miceSerena Marchetti, Nienke A de Vries, Tessa Buckle, et al.
The American Journal of Pathology|February 25, 2003
Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesisFabio Cianchi, Camillo Cortesini, Ornella Fantappiè, et al.
Pageof 4